|
Tri :
Date de référencement
Editeur
Auteur
Titre
|
BRIO's facts and figures, structuration projects : Axe Cancer, translational research centerUpdate the implementation of BRIO
[Ressource pédagogique]
Date de publication :
20141107 |
Auteur(s) :
SOUBEYRAN Pierre-Louis |
Editeur(s) :
Université de Bordeaux - Service Audiovisuel et Multimédia, Université de Bordeaux - Service Audiovisuel et Multimédia |
Origine de la fiche :
Canal-u.fr
Update the implementation of BRIO
Brio organisation is now fully up and running, and more than 100
research projects are currently active into the 6 integrated research
programmes. In addition, major progresses were achieved at the level of the 7
strategic axes defined to structure and support cancer research in Bordeaux.
The bioinformatics axis saw the recruitment of 4 bioinformaticians (2 funded...
Référencé le :
18-12-2014
|
|
Translational cancer genomics and proteomics
[Ressource pédagogique]
Date de publication :
20141107 |
Auteur(s) :
SLEIJFER Stefan |
Editeur(s) :
Université de Bordeaux - Service Audiovisuel et Multimédia, Université de Bordeaux - Service Audiovisuel et Multimédia |
Origine de la fiche :
Canal-u.fr
Translational science : how to move from biology to clinical applicationsEvaluation of cell-free DNA (cfDNA) is a very attractive tool to serve as “liquid biopsy” to define and establish mutational changes in circulating tumor DNA (ctDNA) during cancer therapy.To identify tumor specific mutations in serum ctDNA associated with resistance against tamoxifen in metastatic breast cancer.Ten ER-positiv...
Référencé le :
18-12-2014
|
|
Curing leukemia ?
[Ressource pédagogique]
Date de publication :
20141107 |
Auteur(s) :
MAHON François-Xavier |
Editeur(s) :
Université de Bordeaux - Service Audiovisuel et Multimédia, Université de Bordeaux - Service Audiovisuel et Multimédia |
Origine de la fiche :
Canal-u.fr
Non-pharmaceutical medical innovations and public healthThe use of tyrosine kinase inhibitors (TKIs) targeted against the BCR-ABL1 oncoprotein has proven remarkably successful in chronic myeloid leukemia (CML) and long-term survival has become a reality. Despite this outstanding progress, detection of minimal residual disease precludes therapy termination in most TKI-receiving patients. CML has th...
Référencé le :
18-12-2014
|
|
Multisarc
[Ressource pédagogique]
Date de publication :
20141107 |
Auteur(s) :
ITALIANO Antoine |
Editeur(s) :
Université de Bordeaux - Service Audiovisuel et Multimédia, Université de Bordeaux - Service Audiovisuel et Multimédia |
Origine de la fiche :
Canal-u.fr
Translational science : how to move from biology to clinical applications
Soft-tissues sarcomas
represent an heterogeneous group of tumors. Stadard of care is surgical
resection followed by radiotherapy. Patients with metastatic relapse are
treated with chemotherapy but the overall survival is only approximatly 18
months.
Actual research try to define new therapeutic targets, adapted to the type o...
Référencé le :
18-12-2014
|
|
A new preclinical model to test the response of breast cancer to genomically targeted therapy
[Ressource pédagogique]
Date de publication :
20141107 |
Auteur(s) :
IGGO Richard |
Editeur(s) :
Université de Bordeaux - Service Audiovisuel et Multimédia, Université de Bordeaux - Service Audiovisuel et Multimédia |
Origine de la fiche :
Canal-u.fr
Translational science : how to move from biology to clinical applicationsThe rapid progress in next generation DNA sequencing technology (NGS) means it is now possible, in principle, to obtain a complete list of the genetic abnormalities in a tumour. In practice, clinicians use NGS to obtain a much shorter list of "actionable" mutations that can be targeted with available drugs or used as prognost...
Référencé le :
18-12-2014
|
|
Sociology contribution to understanding the (no)diffusion of a medical innovation
[Ressource pédagogique]
Date de publication :
20141107 |
Auteur(s) :
GORRY Philippe |
Editeur(s) :
Université de Bordeaux - Service Audiovisuel et Multimédia, Université de Bordeaux - Service Audiovisuel et Multimédia |
Origine de la fiche :
Canal-u.fr
Interface
technology/clinical/SHS/public health : case study interventional radiology
We will present results of an undergoing study on the socioeconomic processes of recognition in oncology of a long-standing medical innovation, the so-called interventional radiology (IR). This project is conducted by a multidisciplinary team gathering health sociologist, sociologist of science, economist of inno...
Référencé le :
18-12-2014
|
|
Innovation reimbursement
[Ressource pédagogique]
Date de publication :
20141107 |
Auteur(s) :
FILLATREAU Christian |
Editeur(s) :
Université de Bordeaux - Service Audiovisuel et Multimédia, Université de Bordeaux - Service Audiovisuel et Multimédia |
Origine de la fiche :
Canal-u.fr
Interface
technology/clinical/SHS/public health : case study interventional radiology
Novel diagnostic and therapeutic strategies is a continuum of 3 strongly associated phases : clinical research, medico-economic evaluation of a novel strategy and deployment of innovation, the last one being a field of competence of centers of expertise such as SIRIC BRIO.In the full cycle of innovation, the mone...
Référencé le :
18-12-2014
|
|
BRIO support to scientists
[Ressource pédagogique]
Date de publication :
20141107 |
Auteur(s) :
DESSIS Damien |
Editeur(s) :
Université de Bordeaux - Service Audiovisuel et Multimédia, Université de Bordeaux - Service Audiovisuel et Multimédia |
Origine de la fiche :
Canal-u.fr
BRIO management team was voluntarily built upon various competencies from different horizons (industry, charity…) to provide a broad skillset which aims at supporting the Bordeaux cancer research community. In this section, BRIO highlights the core support the team can bring to scientists. First, in an era of decreasing and competitive public funds, we look into other funding sources, such as Euro...
Référencé le :
18-12-2014
|
|
Bordeaux Cancer Initiative
[Ressource pédagogique]
Date de publication :
20141107 |
Auteur(s) :
DESSIS Damien, ELUSTONDO Frédéric |
Editeur(s) :
Université de Bordeaux - Service Audiovisuel et Multimédia, Université de Bordeaux - Service Audiovisuel et Multimédia |
Origine de la fiche :
Canal-u.fr
Translational science : how to move from biology to clinical applicationsUpon request of the University, the SIRIC was mandated to develop a transversal cancer axis at the University. The axis development was led by BRIO management team along with a committee representing various disciplines within the University having an interest for cancer research. The axis definition focused on cancer researc...
Référencé le :
18-12-2014
|
|
Expert panel discussions : why translational research matters
[Ressource pédagogique]
Date de publication :
20141107 |
Auteur(s) :
CAMERON David |
Editeur(s) :
Université de Bordeaux - Service Audiovisuel et Multimédia, Université de Bordeaux - Service Audiovisuel et Multimédia |
Origine de la fiche :
Canal-u.fr
En point d'orgue du Scientific
BRIO Day, David Cameron, spécialiste reconnu en Oncologie, Professeur à l'Université d'Edimbourg, anime un débat sur la question de la recherche dite translationnelle, que l'on peut considérer comme le chaînon manquant entre recherche fondamentale et recherche clinique. Cette présentation a été donnée dans le cadre du Scientific
BRIO Day 2 organisé annuellement par ...
Référencé le :
18-12-2014
|
|
